Literature DB >> 12126581

Evidence of involvement of central neural mechanisms in generating fibromyalgia pain.

Roland Staud1.   

Abstract

Fibromyalgia syndrome (FMS) is characterized by widespread pain, fatigue, sleep abnormalities, and distress. Because FMS lacks consistent evidence of tissue abnormalities, recent investigations have focused on central nervous system mechanisms of pain. Abnormal temporal summation of second pain (wind-up) and central sensitization have been described recently in patients with FMS. Wind-up and central sensitization, which rely on central pain mechanisms, occur after prolonged C-nociceptor input and depend on activation of nociceptor-specific neurons and wide dynamic range neurons in the dorsal horn of the spinal cord. Other abnormal central pain mechanisms recently detected in patients with FMS include diffuse noxious inhibitory controls. These pain inhibitory mechanisms rely on spinal cord and supraspinal systems involving pain facilitatory and pain inhibitory pathways. Brain-imaging techniques that can detect neuronal activation after nociceptive stimuli have provided additional evidence for abnormal central pain mechanisms in FMS. Brain images have corroborated the augmented reported pain experience of patients with fibromyalgia during experimental pain stimuli. In addition, thalamic activity, which contributes significantly to pain processing, was decreased in fibromyalgia. However, central pain mechanisms of fibromyalgia may not depend exclusively on neuronal activation. Neuroglial activation has been found to play an important role in the induction and maintenance of chronic pain. These findings may have important implications for future research and the treatment of fibromyalgia pain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12126581     DOI: 10.1007/s11926-002-0038-5

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  62 in total

Review 1.  Spinal cord glia: new players in pain.

Authors:  L R Watkins; E D Milligan; S F Maier
Journal:  Pain       Date:  2001-09       Impact factor: 6.961

2.  Cortical and subcortical localization of response to pain in man using positron emission tomography.

Authors:  A K Jones; W D Brown; K J Friston; L Y Qi; R S Frackowiak
Journal:  Proc Biol Sci       Date:  1991-04-22       Impact factor: 5.349

3.  Peripheral suppression of first pain and central summation of second pain evoked by noxious heat pulses.

Authors:  Donald D Price; James W Hu; Ronald Dubner; Richard H Gracely
Journal:  Pain       Date:  1977-02       Impact factor: 6.961

4.  Functional localization of pain perception in the human brain studied by PET.

Authors:  X Xu; H Fukuyama; S Yazawa; T Mima; T Hanakawa; Y Magata; M Kanda; N Fujiwara; K Shindo; T Nagamine; H Shibasaki
Journal:  Neuroreport       Date:  1997-01-20       Impact factor: 1.837

5.  Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis.

Authors:  Henning Vaerøy; Robert Helle; Øystein Førre; Erik Kåss; Lars Terenius
Journal:  Pain       Date:  1988-01       Impact factor: 6.961

Review 6.  Transcriptional and posttranslational plasticity and the generation of inflammatory pain.

Authors:  C J Woolf; M Costigan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

7.  Neurotrophins: peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensitivity.

Authors:  R J Mannion; M Costigan; I Decosterd; F Amaya; Q P Ma; J C Holstege; R R Ji; A Acheson; R M Lindsay; G A Wilkinson; C J Woolf
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

8.  Chronic pain: a PET study of the central effects of percutaneous high cervical cordotomy.

Authors:  V Di Piero; A K P Jones; F Iannotti; M Powell; D Perani; G L Lenzi; R S J Frackowiak
Journal:  Pain       Date:  1991-07       Impact factor: 6.961

9.  Cerebrospinal fluid levels of substance P and calcitonin-gene-related peptide: correlation with sural nerve levels and neuropathic signs in sensory diabetic polyneuropathy.

Authors:  C Tsigos; L T Diemel; A White; D R Tomlinson; R J Young
Journal:  Clin Sci (Lond)       Date:  1993-03       Impact factor: 6.124

10.  Psychophysical and electrophysiological approaches to the pain-relieving effects of heterotopic nociceptive stimuli.

Authors:  J C Willer; A Roby; D Le Bars
Journal:  Brain       Date:  1984-12       Impact factor: 13.501

View more
  55 in total

1.  Stress enhances muscle nociceptor activity in the rat.

Authors:  X Chen; P G Green; J D Levine
Journal:  Neuroscience       Date:  2011-04-15       Impact factor: 3.590

Review 2.  Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide.

Authors:  Salih Ozgocmen; Huseyin Ozyurt; Sadik Sogut; Omer Akyol
Journal:  Rheumatol Int       Date:  2005-11-20       Impact factor: 2.631

3.  A randomized, double-blind, placebo-controlled clinical trial using a low-frequency magnetic field in the treatment of musculoskeletal chronic pain.

Authors:  Alex W Thomas; Karissa Graham; Frank S Prato; Julia McKay; Patricia Morley Forster; Dwight E Moulin; Sesh Chari
Journal:  Pain Res Manag       Date:  2007       Impact factor: 3.037

Review 4.  Mechanisms of drug combinations: interaction and network perspectives.

Authors:  Jia Jia; Feng Zhu; Xiaohua Ma; Zhiwei Cao; Zhiwei W Cao; Yixue Li; Yixue X Li; Yu Zong Chen
Journal:  Nat Rev Drug Discov       Date:  2009-02       Impact factor: 84.694

5.  Efficacy of duloxetine in patients with fibromyalgia: pooled analysis of 4 placebo-controlled clinical trials.

Authors:  Lesley M Arnold; Daniel J Clauw; Madelaine M Wohlreich; Fujun Wang; Jonna Ahl; Paula J Gaynor; Amy S Chappell
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

Review 6.  Predictors of clinical pain intensity in patients with fibromyalgia syndrome.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

7.  Short-term efficacy of topical capsaicin therapy in severely affected fibromyalgia patients.

Authors:  Benigno Casanueva; Baltasar Rodero; Covadonga Quintial; Javier Llorca; Miguel A González-Gay
Journal:  Rheumatol Int       Date:  2012-07-28       Impact factor: 2.631

Review 8.  Psychological screening/phenotyping as predictors for spinal cord stimulation.

Authors:  Claudia M Campbell; Robert N Jamison; Robert R Edwards
Journal:  Curr Pain Headache Rep       Date:  2013-01

9.  Proinflammatory cytokine levels in fibromyalgia patients are independent of body mass index.

Authors:  Maria E Hernandez; Enrique Becerril; Mayra Perez; Philippe Leff; Benito Anton; Sergio Estrada; Iris Estrada; Manuel Sarasa; Enrique Serrano; Lenin Pavon
Journal:  BMC Res Notes       Date:  2010-06-03

10.  The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study.

Authors:  Yvonne C Lee; Lori B Chibnik; Bing Lu; Ajay D Wasan; Robert R Edwards; Anne H Fossel; Simon M Helfgott; Daniel H Solomon; Daniel J Clauw; Elizabeth W Karlson
Journal:  Arthritis Res Ther       Date:  2009-10-29       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.